$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Abstract

The objective of this study was to characterize immunoliposomes carrying plasmid DNA with optimal encapsulation efficiency and antibody density. Plasmid DNA was encapsulated by the freezing/thawing method into liposomes composed of POPC (1-palmitoyl-2-oleoyl-sn-glycerol- 3-phosphocholine), DDAB (didodecyl dimethyl ammonium bromide), DSPE-PEG 2000 (distearoyl phosphatidyl ethanolamine polyethylene glycol 2000) and DSPE-PEG 2000-maleimide. The liposomes carrying plasmid DNA were extruded through two stacked polycarbonate filters, of different pore size, to control the liposome size. Then, rat IgG molecules were conjugated to the liposomes. The immunoliposomes containing plasmid DNA were separated from the free plasmid DNA and unconjugated IgG by Sepharose CL-4B column chromatography. The DNA amount encapsulated was affected by DDAB (cationic lipid) concentration, the initial amount of plasmid DNA between 10 ${\mu}g$ and 200 ${\mu}g$, the total lipid amount and plasmid DNA size, but not significantly by liposome size. By varying the ratio of DSPE-PEG 2000-maleimide to IgG, the number of IgG molecules per liposome was changed significantly.

참고문헌 (24)

  1. Boris-Lawrie, K. A. and Temin, H. M., Recent advances in retrovirus vectortechnology. Curr. Opin. Genet. Dev., 3, 102-109 (1993) 
  2. Li, S. and Huang, L., In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 4, 891-900 (1997) 
  3. Pastorino, F., Stuart, D., Ponzoni, M., and Allen, T. M., Targeted delivery of antisense oligonucleotides in cancer. J. Control Release, 74, 69-75 (2001) 
  4. Setoguchi, Y., Jaffe, H. A., Chu, C.-S., and Crystal, R. G., Intraperitoneal in vivo gene therapy to deliver alpha 1antitrypsin to the systemic circulation. Am. J. Resp. Cell. Mol. BioI., 10, 369-377 (1994) 
  5. Worgall, S., Wolff, G., Falck-Pedersen, E., and Crystal, R. G., Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther., 8, 37-44 (1997) 
  6. Li, S. and Huang, L., Nonviral gene therapy: promises and challenges. GeneTher., 7, 31-34 (2000) 
  7. Huwyler, J., Dafang, W., and Pardridge, W. M., Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. U.S.A., 93,14164-14169 (1996) 
  8. Maruyama, K., Ishida, O., Takizawa, T., and Moribe, K., Possibility of active targeting to tumor tissues with liposomes. Adv. Drug Deliv. Rev., 40, 89-102 (1999) 
  9. Schatzlein, A. G., Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs, 12, 275-304 (2001) 
  10. Smith, T. A., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., and Kaleko, M., Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet., 5, 397-402 (1993) 
  11. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M., Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U. S. A., 91, 4470-4411 (1995b) 
  12. Park, H. M., Chung, S. Y., Go, E. J., and Lee, H. J., Preparation and characterization of plasmid DNA encapsulated in liposomes. J. Kor. Pharm. Sci., 33, 209-213 (2003) 
  13. Yang, Y., Li, Q., Ertl, H. C., and Wilson, J. M., Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69, 2004-2015 (1995a) 
  14. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W., Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediated specific and efficient drug delivery to EGFR- and EGFRvllloverexpressing tumor cells. Cancer Res., 63, 3154-3161 (2003) 
  15. Stuart, D. D. and Allen, T. M., A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta,1463, 219-229 (2000) 
  16. Bailey, A. L. and Sullivan, S. M., Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta, 1468, 239-252 (2000) 
  17. Shi, N. and Pardridge, W. M., Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A., 97, 7567-7572 (2000) 
  18. Lamb, B. T., Sisodia, S. S., Lawler, A. M., Siunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., and Gearhart, J. D., Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet., 5, 22-30 (1993) 
  19. Monnard, P.-A., Oberholzer,T., and Luisi, P. L., Entrapment of nucleic acids in liposomes. Biochim. Biophys. Acta,1329, 3950 (1997) 
  20. Pardridge, W. M., Buciak, J. L., and Yoshikawa, T., Transport of recombinant CD4 through the rat blood-brain barrier in vivo. J. Pharmacol. Exp. Ther., 261, 1175-1180 (1992) 
  21. Saravolac, E. G., Ludkovski,O., Skirrow, R., Ossanlou, M., Zhang, Y. P., Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, P. R., and Scherrer, P., Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J. Drug Target, 7, 423-437 (2000) 
  22. Nabel, G. J., Nabel, E. G., Yang, Z.-Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A. E., Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A., 90, 11307-11311 (1993) 
  23. Harrison, G. S.,Wang, Y., Tomezak, J., Hogan, C., Shpall, E. J., Curiel, T. J., and Feigner, P. L., Optimization of genetransfer using cationic lipids in cell lines and primary human CD4+ and CD34 hematopoietic cells. Biotechniques, 19, 816-823 (1995) 
  24. Miller, A. D., Retroviral vectors. Curr. Top. Microbiol. Immunol., 158, 1-24 (1992) 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일